Calciscon develops and markets the first and only diagnostic blood test to measure the likelihood of calcification in the blood. Kidney patients often have heightened levels of calcification. The Calciscon test offers new diagnostic, treatment and prognosis options.
Plus de détails Plus de détailsAt least two Swiss teams hold solar world records: Solar Impulse and AtlantikSolar. In 2016, Solar Impulse completed the first ever around-the-world flight in a purely solar-powered airplane. EPFL and Empa were key partners. AtlantikSolar, developed at ETH Zurich, holds the world record for the longest fully solar-powered flight ever (81 hours) of an unmanned aerial vehicle (UAV).
Plus de détailsThis breakthrough technology for deep-seated tumor irradiation has become one of the leading forms of tumor and cancer treatment around the world. With proton therapy, tumor tissues are destroyed using protons.
Plus de détailsIn 2016, the first ever Olympic-style competition for disabled people using robotics-based assistive technologies took place in Zurich: Cybathlon.
Plus de détailsMIRACLE, short for Minimally Invasive Robot-Assisted Computer-guided LaserosteotomE, aims to develop a robotic endoscope to perform contact-free bone surgery with laser light.
Plus de détailsMedical Application of Virtual and Augmented Reality Tools. With the Virtual Reality tool SpectoVR, doctors can interact in a three-dimensional space with the patient data prior to surgery.
Plus de détailsevolaris aviation gmbh – a spin-off of the Bern University of Applied science – has developed an electrical high power aerobatic motor for the swiss aerobatic aircraft VOTEC 221 in the past 2 years.
Plus de détailsStoring solar energy as hydrogen is a promising way for developing comprehensive renewable energy systems. Building on a unique idea, EPFL scientists have now developed a simple, unconventional method to fabricate high-quality, efficient solar panels for direct solar hydrogen production with low cost.
Plus de détailsInhale, then exhale. This simple act could now save lives. A technology developed in part at EPFL can quickly identify the presence of a head and neck cancer, such as of the throat or mouth by analysing people's breath. The new device, equipped with extremely sensitive sensors, has been tested on patients and operates with a computer or even a mobile phone.
Plus de détailsMembrane protein drug targets represent a significant challenge for high-resolution three-dimensional structure determination limiting the discovery and development of novel medicines. leadXpro AG, a company at PARK INNOVAARE, successfully tackles the membrane protein structure identification challenge to advance the drug discovery process and bring better drugs to the market.
Plus de détailsEPFL scientists have developed a method that improves the accuracy of DNA sequencing up to a thousand times. The method, which uses nanopores to read individual nucleotides, paves the way for better – and cheaper – DNA sequencing. Reading the exact make-up of genes, scientists can detect mutations, or even identify different organisms.
Plus de détailsIn 2016 a new organisation, Switzerland Innovation – the Swiss innovation park, started operating in Switzerland. It is a platform that unites five innovation...
Plus de détails